Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Non Operating Income (2010 - 2026)

Harvard Bioscience (HBIO) reported Non Operating Income of -$405000.0 for Q1 2026, up 64.03% year-over-year from -$246903.1 in Q1 2025, and down 109.88% on a QoQ basis from $4.1 million in Q4 2025.

Harvard Bioscience (HBIO) has 17 years of Non Operating Income data on file, last reported at -$405000.0 in Q1 2026.

  • Quarterly Non Operating Income rose 64.03% year-over-year to -$405000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 180.3% YoY) and the FY2025 annual result came in at $208000.0, up 103.81% from the prior year.
  • Non Operating Income slipped to -$405000.0 in Q1 2026 per HBIO's latest filing, from $4.1 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $4.1 million in Q4 2025 and bottomed at -$2.9 million in Q2 2023.
  • The 5-year median for Non Operating Income is -$332000.0 (2023), against an average of -$272764.7.
  • The widest annual swing landed in 2024, when Non Operating Income plunged 5915.56%; it then jumped 608.12% in 2025.
  • Tracing HBIO's Non Operating Income over 5 years: stood at $2.1 million in 2022, then sank by 115.71% to -$332000.0 in 2023, then surged by 274.4% to $579000.0 in 2024, then jumped by 608.12% to $4.1 million in 2025, then slumped by 109.88% to -$405000.0 in 2026.
  • Per Business Quant, the three latest HBIO Non Operating Income figures stand at -$405000.0 (Q1 2026), $4.1 million (Q4 2025), and -$365000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 85.10 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 86.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -1.37 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -200,000.00
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -4.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 1.80 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 3.02 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -6.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -53,000.00
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn -405,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -405,000.00
Dec 31, 2025 4.10 Mn
Sep 30, 2025 -365,000.00
Jun 30, 2025 -644,000.00
Mar 31, 2025 -1.13 Mn
Dec 31, 2024 579,000.00
Sep 30, 2024 -2.62 Mn
Jun 30, 2024 -181,000.00
Mar 31, 2024 -2.21 Mn
Dec 31, 2023 -332,000.00
Sep 30, 2023 45,000.00
Jun 30, 2023 -2.89 Mn
Mar 31, 2023 -542,000.00
Dec 31, 2022 2.11 Mn
Sep 30, 2022 -179,000.00
Jun 30, 2022 -62,000.00
Mar 31, 2022 78,000.00
Dec 31, 2021 -1.73 Mn
Sep 30, 2021 -130,000.00
Jun 30, 2021 -690,000.00
Mar 31, 2021 -34,000.00
Dec 31, 2020 3.40 Mn
Sep 30, 2020 -1.60 Mn
Jun 30, 2020 -1.42 Mn
Mar 31, 2020 111,000.00
Dec 31, 2019 -1.54 Mn
Sep 30, 2019 -1.31 Mn
Jun 30, 2019 16,000.00
Mar 31, 2019 -1.67 Mn
Dec 31, 2018 -1.70 Mn
Sep 30, 2018 -1.80 Mn
Jun 30, 2018 -1.49 Mn
Mar 31, 2018 -3.98 Mn
Dec 31, 2017 -849,000.00
Sep 30, 2017 -274,000.00
Jun 30, 2017 -463,000.00
Mar 31, 2017 -400,000.00
Dec 31, 2016 135,000.00
Sep 30, 2016 -67,000.00
Jun 30, 2016 73,000.00
Mar 31, 2016 -222,000.00
Dec 31, 2015 -434,000.00
Sep 30, 2015 -321,000.00
Jun 30, 2015 -526,000.00
Mar 31, 2015 -614,000.00
Dec 31, 2014 -949,000.00
Sep 30, 2014 -469,000.00
Jun 30, 2014 -468,000.00
Mar 31, 2014 -315,000.00
Dec 31, 2013 -319,000.00
Sep 30, 2013 -358,000.00
Jun 30, 2013 -330,000.00
Mar 31, 2013 -95,000.00
Dec 31, 2012 -149,000.00
Sep 30, 2012 -178,000.00
Jun 30, 2012 -226,000.00
Mar 31, 2012 -385,000.00
Dec 31, 2011 -403,000.00
Sep 30, 2011 -338,000.00
Jun 30, 2011 -519,000.00
Mar 31, 2011 -275,000.00
Dec 31, 2010 26,000.00
Sep 30, 2010 -380,000.00
Jun 30, 2010 125,000.00